Leica Biosystems and Indica Labs Announce Significant Strategic Investment and Creation of Digital Pathology Platform

Leica Biosystems and Indica Labs: Combining leading hardware and software is expected to provide a compelling solution for digital pathology users across the full translational medicine paradigm, from early biomarker discovery to clinical...

CorePlus and Ibex: Digital pathology leader surpasses 250,000 AI-based analyses in routine clinical use as it incorporates Ibex Prostate for TURP to further enhance diagnostic precision. CAROLINA, Puerto Rico & BOSTON--(BUSINESS...

NEW YORK--(BUSINESS WIRE)--Ataraxis AI, a frontier artificial intelligence (AI) research lab developing AI-powered tools for oncology, today announced Ataraxis™ Breast CTX, a new predictive capability within its Ataraxis Breast...

Lunit, CellCarta: Partnership combines Lunit's platform-agnostic AI pathology algorithms with CellCarta's global CDx development and laboratory execution to help biopharma teams de-risk assets and accelerate evidence generation and CDx launch...

Lumea: IMS Viewer+ (FDA-cleared and CE-marked under IVDR) now seamlessly incorporates Cleo Skin, Primaa’s AI solution, into dermpaths' digital workflows. LEHI, UT, UNITED STATES, March 24, 2026 /EINPresswire.com/ -- Lumea, the U.S. leader in...

HNL Lab Medicine to integrate Ibex’s AI-powered solution for prostate cancer, building on its existing digital pathology foundation to support high-precision diagnostics BOSTON & ALLENTOWN, Pa.--(BUSINESS WIRE)--Ibex...